HAVN Life Sciences Inc logo

HAVN Life Sciences Inc

NEW
XCNQ:HAVN (Canada)   Ordinary Shares
C$ 0.030 (0%) Jul 1
At Loss
Market Cap:
C$ 442.00K ($ 325.00K)
Enterprise V:
C$ 454.00K ($ 334.00K)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

HAVN Life Sciences Inc logo
HAVN Life Sciences Inc
NAICS : 541714 SIC : 3741
ISIN : CA4196213058

Share Class Description:

XCNQ:HAVN: Ordinary Shares
Description
HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -444.63

GF Value Rank

Name Current Vs Industry Vs History